Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
VP

Ved Pathak — 9 Patents

TATargegen: 6 patents #6 of 19Top 35%
APAgouron Pharmaceuticals: 2 patents #119 of 327Top 40%
Pfizer: 2 patents #2,085 of 5,153Top 45%
San Diego, CA: #4,726 of 23,606 inventorsTop 25%
California: #67,547 of 386,348 inventorsTop 20%
Overall (All Time): #535,341 of 4,157,543Top 15%
9 Patents All Time
Ved Pathak has been granted 9 US patents while listed as an inventor at Targegen. The first was granted in 2004 and the most recent in December 2013. Ved Pathak ranks #535,341 of 4,157,543 US inventors in our database (top 12.9%). Patent records list Ved Pathak in San Diego, CA, US.

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
8604042 Bi-aryl meta-pyrimidine inhibitors of kinases Glenn Noronha, Chi Ching Mak, Jianguo Cao, Joel Renick, Andrew McPherson +4 more 2013-12-10
8481536 Benzotriazine inhibitors of kinases Xianchang Gong, Kathy Barrett, Jianguo Cao, Colleen Gritzen, Glenn Noronha +10 more 2013-07-09
8030487 2-amino—5-substituted pyrimidine inhibitors Glenn Noronha, Jianguo Cao, Colleen Gritzen, Chi Ching Mak, Andrew McPherson +4 more 2011-10-04
7825246 Bi-aryl meta-pyrimidine inhibitors of kinases Glenn Noronha, Chi Ching Mak, Jianguo Cao, Joel Renick, Andrew McPherson +4 more 2010-11-02
7528143 Bi-aryl meta-pyrimidine inhibitors of kinases Glenn Noronha, Chi Ching Mak, Jianguo Cao, Joel Renick, Andrew McPherson +4 more 2009-05-05
7456176 Benzotriazine inhibitors of kinases Glenn Noronha, Kathy Barrett, Jianguo Cao, Colleen Gritzen, Xianchang Gong +10 more 2008-11-25
7101878 Non-peptide GNRH agents, methods and intermediates for their preparation Mark B. Anderson, Haresh Vazir, David Luthin, Genevieve DeGuzman Paderes, Lance Christie +4 more 2006-09-05
6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use Mark B. Anderson, Lance Christie, Quyen-Quyen Do, Jun Feng, Yufeng Hong +4 more 2005-06-07 $269,655,000
6833372 Non-peptide GnRH agents, Pharmaceutical compositions, and methods for their use Lance Christie, Mark B. Anderson, Jun Feng, Yufeng Hong, Ranjan Rajapakse +3 more 2004-12-21 $268,691,000